top of page

Recent Posts

Search

Hope of cancer breakthrough as ‘groundbreaking pill’ annihilates ALL solid tumours in early study

OPACC
Aug 3, 2023
1 min read

In early studies, the targeted chemotherapy drug has shown to annihilate tumours without affecting surrounding healthy cells.

Read more: https://www.the-sun.com/health/8745625/cancer-drug-breakthrough-aoh1996/

Recent Posts

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...

Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...

Comments

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe

New approach speeds up personalized cancer treatment for young patients

Motor Deficits in Children Off Therapy for Acute Lymphoblastic Leukemia

Boys with cancer can face infertility as adults. Can storing their stem cells help?

HRD HSCT Shows Promise Among Pediatric Patients With Hematologic Cancers

Treating a deadly childhood cancer with a sideways approach

Childhood Cancer Survivors Have Higher Risk of Chronic Conditions, Early Death

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

Archive

Search By Tags

bottom of page